Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Natera Inc
(NQ:
NTRA
)
96.98
+3.26 (+3.48%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Natera Inc
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Natera's Debt Overview
February 22, 2022
Over the past three months, shares of Natera (NASDAQ:NTRA) decreased by 34.50%. Before we understand the importance of debt, let us look at how much debt Natera has. Check...
Via
Benzinga
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
February 20, 2022
Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries. On the regulatory front...
Via
Benzinga
NASDAQ:NTRA Investor Alert: Investigation over Possible Securities Laws Violations by Natera, Inc.
January 28, 2022
San Diego, CA -- (SBWIRE) -- 01/28/2022 -- Natera, Inc are under investigation over potential securities laws violations in connection with certain financial statements.
Via
SBWire
INVESTOR ALERT: Kirby McInerney LLP Continues Investigation of Shareholder Claims on Behalf of Natera, Inc. (NTRA) Investors
January 26, 2022
From
Kirby McInerney LLP
Via
Business Wire
Investigation Notice: The Schall Law Firm Encourages Investors in Natera, Inc. with Losses of $100,000 to Contact the Firm
January 24, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Investigation Alert: The Schall Law Firm Encourages Investors in Natera, Inc. with Losses of $100,000 to Contact the Firm
January 21, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Ongoing Investigation Reminder: The Schall Law Firm Encourages Investors in Natera, Inc. with Losses of $100,000 to Contact the Firm
January 20, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Landmark SMART Study Demonstrates High Accuracy of Natera’s Panorama® NIPT for 22q11.2 Deletion Screening
January 20, 2022
From
Natera
Via
Business Wire
Investigation Notice: The Schall Law Firm Encourages Investors in Natera, Inc. with Losses of $100,000 to Contact the Firm
January 19, 2022
Los Angeles - (NewMediaWire) - January 19, 2022 - The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Natera, Inc....
Via
NewMediaWire
INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in Natera, Inc. with Losses of $100,000 to Contact the Firm
January 19, 2022
From
The Schall Law Firm
Via
Business Wire
SHAREHOLDER ALERT: Robbins LLP Investigates Natera, Inc. (NTRA) on Behalf of Shareholders
January 18, 2022
From
Robbins LLP
Via
Business Wire
INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Natera, Inc. with Losses of $100,000 to Contact the Firm
January 18, 2022
From
The Schall Law Firm
Via
Business Wire
ROSEN, A LEADING LAW FIRM, Encourages Natera, Inc. Investors with Losses to Inquire About Class Action Investigation – NTRA
January 17, 2022
From
Rosen Law Firm
Via
Business Wire
FeganScott Announces Investigation into Prenatal Testing Options Revealing Flawed Genetic Results
January 17, 2022
--News Direct--
Via
News Direct
INVESTOR ALERT: Kirby McInerney LLP Continues Investigation of Shareholder Claims on Behalf of Natera, Inc. (NTRA) Investors
January 11, 2022
From
Kirby McInerney LLP
Via
Business Wire
SHAREHOLDER ALERT: Robbins LLP Investigates Natera, Inc. (NTRA) on Behalf of Shareholders
January 10, 2022
From
Robbins LLP
Via
Business Wire
Stocks That Hit 52-Week Lows On Friday
January 07, 2022
Before 10 am on Friday, 110 companies set new 52-week lows. Interesting Points From Today's 52-Week Lows: Humana (NYSE:HUM) was the biggest company on a market cap...
Via
Benzinga
Natera Announces Expansion Into Early Cancer Detection and Screening
January 06, 2022
From
Natera, Inc.
Via
Business Wire
NATERA ALERT: Bragar Eagel & Squire, P.C. is Investigating Natera, Inc. on Behalf of Natera Stockholders and Encourages Investors to Contact the Firm
January 04, 2022
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Natera, Inc. (NTRA) on Behalf of Investors
January 03, 2022
From
Glancy Prongay & Murray LLP
Via
Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Natera, Inc. (NTRA) on Behalf of Investors
January 03, 2022
From
The Law Offices of Frank R. Cruz
Via
Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Natera, Inc. (NTRA) on Behalf of Investors
January 03, 2022
From
Law Offices of Howard G. Smith
Via
Business Wire
7 Stocks to Buy in November in Light of Their October Dip
November 15, 2021
October was a good month in the markets. It won't be easy to find stocks to buy on the dip. However, here are seven that will do the trick.
Via
InvestorPlace
Medicare Coverage For Natera's Signatera For Pan-Cancer Immunotherapy Monitoring
November 11, 2021
CMS Molecular Diagnostics Services Program (MolDX) has issued a final local coverage determination (LCD) for pan-cancer immunotherapy monitoring using Natera Inc...
Via
Benzinga
Natera Raises FY21 Sales Outlook After Mixed Q3 earnings
November 05, 2021
Natera Inc (NASDAQ: NTRA) posted Q3 sales of $158.1 million, +61% Y/Y, beating the consensus of $151.36 million, driven by an increase in test volume and product...
Via
Benzinga
Natera Inc (NTRA) Q3 2021 Earnings Call Transcript
November 05, 2021
NTRA earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
CEO And President Of Natera Trades $2.4M In Company Stock
October 06, 2021
Leonard Steven Chapman, CEO And President at Natera (NASDAQ:NTRA), made a large buy and sell of company shares on October 5, according to a new SEC filing. What Happened: A Form 4...
Via
Benzinga
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Notable Natera Insider Trades $3M In Company Stock
September 30, 2021
Burkes Michael Brophy, Chief Financial Officer at Natera (NASDAQ:NTRA), made a large buy and sell of company shares on September 28, according to a new SEC filing. What Happened:...
Via
Benzinga
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO
November 04, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &...
Via
Benzinga
Exposures
COVID-19
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.